Evidence map›Paper›PMID 40588846›Full record

ReviewInsect science2026

The JAK-STAT pathway in invertebrates: An emerging battleground for host‒virus warfare.

Hengchuan Xia, Cong Zhang, Zhongjian Guo, Liang Chen, Keping Chen

Abstract readReview
In one paragraph

Review in Insect science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. ThemicroPublication biology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hengchuan Xia *School of Life Sciences, Jiangsu University, Zhenjiang, Jiangsu Province, China.
Cong Zhang *School of Life Sciences, Jiangsu University, Zhenjiang, Jiangsu Province, China.ORCID https://orcid.org/0009-0006-3594-170X
Zhongjian GuoSchool of Life Sciences, Jiangsu University, Zhenjiang, Jiangsu Province, China.
Liang ChenSchool of Life Sciences, Jiangsu University, Zhenjiang, Jiangsu Province, China.ORCID https://orcid.org/0000-0003-4760-5165
Keping ChenSchool of Life Sciences, Jiangsu University, Zhenjiang, Jiangsu Province, China.

Funding

National Natural Science Foundation of China 31372259
6 · The paper itself

Abstract

The arms race between hosts and viruses for dominance over the Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway has been extensively studied in vertebrates but remains poorly explored in invertebrates. Recent studies have revealed that the antiviral Vago/JAK-STAT pathway in invertebrates operates as a parallel mechanism to the vertebrate interferon (IFN)/JAK-STAT pathway, suggesting a highly conserved antiviral mechanism across the animal kingdom. Moreover, invertebrates appear to employ multifaceted strategies to modulate the JAK-STAT pathway to inhibit viral replication or enhance host tolerance, while viruses can counteract by manipulating the JAK-STAT pathway to their advantage. Thus, the competition between hosts and viruses for control of the JAK-STAT pathway also exists in invertebrates, indicating this arms race is also conserved in evolution. This review summarizes the discovery of the Vago/JAK-STAT pathway, its comparison to the IFN/JAK-STAT pathway, and the mechanisms underlying the host-virus tug-of-war over the JAK-STAT pathway in invertebrates. These insights shed light on this highly conserved immune strategy, its implication for host-virus interaction, and its potential application in disease control.

Indexed as

InvertebratesJanus KinasesSignal TransductionSTAT Transcription FactorsAnimalsHost-Pathogen InteractionsJanus KinasesSTAT Transcription FactorsIFNinvertebrateJAK‐STATSOCSVagovirus

Identifiers

PMID40588846
PMCPMC13440986

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.